ExpreS2ion Biotech Holding Balance Sheet Health
Financial Health criteria checks 6/6
ExpreS2ion Biotech Holding has a total shareholder equity of SEK69.3M and total debt of SEK358.0K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are SEK104.5M and SEK35.2M respectively.
Key information
0.5%
Debt to equity ratio
SEK 358.00k
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 76.40m |
| Equity | SEK 69.35m |
| Total liabilities | SEK 35.17m |
| Total assets | SEK 104.52m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: EXPRS2's short term assets (SEK94.7M) exceed its short term liabilities (SEK33.2M).
Long Term Liabilities: EXPRS2's short term assets (SEK94.7M) exceed its long term liabilities (SEK2.0M).
Debt to Equity History and Analysis
Debt Level: EXPRS2 has more cash than its total debt.
Reducing Debt: EXPRS2's debt to equity ratio has reduced from 16.5% to 0.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXPRS2 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EXPRS2 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 32.7% each year.